Neuroendocrine Lesions Arising From Mediastinal Teratoma-A Case Report and Literature Review.
Pensi P H LamRay T W LumJoyce W Y ChanRainbow W H LauCalvin Sze-Hang NgJoshua Jing Xi LiPublished in: International journal of surgical pathology (2024)
Background. Neuroendocrine lesions arising from mediastinal teratomas are rare tumors with only small number of patients reported in literature. The behavior of these lesions appears to be different from traditional neuroendocrine neoplasms. A comprehensive review will be valuable for histologic assessment and treatment planning for similar cases. Case presentation. We present an example of a 57-year-old man who presented with cough. Subsequent work-up revealed an anterior mediastinal mass of 2.1 cm on computed tomography. The patient underwent robot-assisted thoracoscopic thymectomy. Histological examination revealed a mature cystic teratoma with a neuroendocrine component consisting of clusters of tumor cells with round to oval nuclei and a "salt-and-pepper" chromatin pattern. The tumor cells were immunoreactive to cytokeratin, synaptophysin, chromogranin, and INSM1, with a Ki-67 proliferative index of 4%. A histological diagnosis was mature teratoma with well-differentiated low-grade neuroendocrine tumor (carcinoid) was made. The patient was well and without disease after complete surgical excision at 10 months. Literature review. Literature reviewed yielded 13 examples of neuroendocrine lesions arising from mediastinal teratomas. No disease-related mortality was reported, even in lesions with high-grade neuroendocrine, carcinomatous, or immature teratomatous components. Conclusions. Surgical removal is the mainstay of treatment of these lesions, and the presence of a neuroendocrine component does not appear to negatively affect prognosis.
Keyphrases
- low grade
- high grade
- robot assisted
- lymph node
- computed tomography
- case report
- systematic review
- ultrasound guided
- gene expression
- magnetic resonance imaging
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- type diabetes
- prognostic factors
- radiation therapy
- dna methylation
- contrast enhanced
- drug induced